甘李药业：关于公司持股5%以上股东部分股份解押的公告

Core Points - Gannee Pharmaceutical announced that Beijing Xute Hongda Technology Co., Ltd. holds 32,073,734 shares of the company, accounting for 5.37% of the total share capital [1] - On October 20, 2025, the company received notification that Xute Hongda has completed the release registration procedures for 600,000 shares [1] - After the release of the pledge, Xute Hongda has pledged a total of 23,410,000 shares, which is 72.99% of its holdings and 3.92% of the company's total share capital [1]